Clinical Trial Update: Pasireotide Therapy in Patients With Nelson's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing pasireotide for Nelson's syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nelson Syndrome

Drugs mentioned

• SIGNIFOR (PASIREOTIDE)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Nelson Syndrome | Phase 2 | Status: TERMINATED